NCT04843683View on ClinicalTrials.gov

StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias (START-CA)

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Cardiac Arrhythmia
Interventions
RADIATION

Stereotactic Ablative Radiotherapy

Stereotactic ablative radiotherapy (SBRT) is a type of radiation treatment that delivers precise, high dose radiation to targeted areas. In this study, a single treatment of SBRT will be delivered to the abnormal area of a participant's heart that is causing dangerous heart rate and rhythm changes (arrhythmia).

Trial Locations (1)

M5G 2M9

RECRUITING

Princess Margaret Cancer Center, University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER